Press releases

New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More

The internationally renowned scientific journal "Nature" publishes in today's issue an article about plectasin, which is a great acknowledgement of the work carried out within the research project. More

The Norwegian Radium Hospital Research Foundation and Cancer Research Technology form a strategic alliance More

Commercialising technologies from universities and research institutes is crucial to building a viable biotechnology sector. More

The CONRAD program of the Eastern Virginia Medical School today announced that it has received a $12M grant from the Bill & Melinda Gates Foundation, with $12 million in matching funds committed by the US Agency for International Development (USA More

Novozymes has discovered Plectasin, an antimicrobial peptide (AMP) that acts on bacterial infections that have developed resistance to conventional antibiotics. More

Foamix Ltd. announced today that on November 22, 2005 the United States Patent and Trademark Office (USPTO) issued to Foamix Patent No. 6,967,023. More

University of Dundee wins award for work with pharma partners. More